You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

~ Buy the SAXENDA (liraglutide recombinant) Drug Profile, 2024 PDF Report in the Report Store ~

List of Excipients in Branded Drug saxenda

✉ Email this page to a colleague

« Back to Dashboard

Glossary

Subscribe to access the full database, or Try a Trial
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novo Nordisk	SAXENDA	liraglutide	0169-2800	PHENOL	2026-02-13
Novo Nordisk	SAXENDA	liraglutide	0169-2800	PROPYLENE GLYCOL	2026-02-13
Novo Nordisk	SAXENDA	liraglutide	0169-2800	SODIUM PHOSPHATE, DIBASIC, DIHYDRATE	2026-02-13
Novo Nordisk	SAXENDA	liraglutide	0169-2800	WATER	2026-02-13
A-S Medication Solutions	SAXENDA	liraglutide	50090-4257	PHENOL	2026-02-13
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.